What is the recommended treatment for impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Impetigo

For localized impetigo (limited lesions), treat with topical mupirocin or retapamulin twice daily for 5 days; for extensive disease or multiple lesions, use oral antibiotics for 7 days targeting S. aureus. 1

Treatment Algorithm Based on Disease Extent

Localized Disease (Few Lesions)

Topical therapy is first-line:

  • Mupirocin 2% ointment applied twice daily for 5 days (strong evidence) 1
  • Retapamulin 1% ointment applied twice daily for 5 days (strong evidence) 1

These topical agents are equally effective as oral antibiotics for limited disease and have the advantage of fewer systemic side effects 2, 3. Meta-analysis demonstrates topical antibiotics are significantly more effective than placebo (RR 2.24,95% CI 1.61-3.13) 2.

Extensive Disease (Numerous Lesions) or Outbreak Settings

Oral antibiotics are recommended to decrease transmission and for more rapid clearance 1:

First-line oral agents (7-day course):

  • Dicloxacillin 250 mg four times daily (adults) or 25-50 mg/kg/day divided in 4 doses (children) 1
  • Cephalexin 250 mg four times daily (adults) or 25-50 mg/kg/day divided in 3-4 doses (children) 1

These agents target methicillin-susceptible S. aureus (MSSA), which causes most impetigo cases 1.

If MRSA is suspected or confirmed:

  • Doxycycline 100 mg twice daily (avoid in children <8 years) 1
  • Clindamycin 300-400 mg four times daily (adults) or 20 mg/kg/day divided in 3 doses (children) 1
  • Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily (adults) or 8-12 mg/kg/day based on TMP component (children) 1

If Streptococcus Alone is Cultured

Oral penicillin becomes the drug of choice, with macrolides or clindamycin as alternatives for penicillin-allergic patients 1.

Important Clinical Considerations

Culture is helpful but not mandatory: While Gram stain and culture can identify whether S. aureus and/or β-hemolytic Streptococcus is the cause, treatment without cultures is reasonable in typical cases 1. However, cultures should be obtained if MRSA is suspected or in treatment failures.

Topical vs. oral efficacy: Topical mupirocin has been shown slightly superior to oral erythromycin (pooled RR 1.07,95% CI 1.01-1.13) 2. There is no significant difference between topical and other oral antibiotics for limited disease, but oral therapy is preferred when lesions are numerous to reduce transmission 1.

Avoid penicillin for empiric therapy: Penicillin alone is inferior to other antibiotics (inferior to erythromycin RR 1.29, and to cloxacillin RR 1.59) because most impetigo is caused by S. aureus, which produces penicillinase 2.

Common Pitfalls to Avoid

  • Don't use topical antibiotics for extensive disease - oral therapy is more practical and helps reduce community transmission 1
  • Don't prescribe penicillin empirically - it's only appropriate when cultures confirm streptococcal infection alone 1
  • Be aware of local resistance patterns - increasing resistance to mupirocin, fusidic acid, and erythromycin has been reported globally 4, 5
  • Avoid erythromycin as first-line - resistance rates are high in both S. aureus and S. pyogenes 1

Special Circumstances

During outbreaks of post-streptococcal glomerulonephritis: Use systemic antimicrobials to help eliminate nephritogenic strains of S. pyogenes from the community 1.

Ecthyma (deeper infection): Always requires oral antibiotics rather than topical therapy, using the same agents as for extensive impetigo 1.

Side effects: Oral antibiotics cause more side effects than topical agents, primarily gastrointestinal symptoms 2. Topical therapy has minimal adverse effects and should be maximized when appropriate.

References

Research

Interventions for impetigo.

The Cochrane database of systematic reviews, 2012

Research

A systematic review and meta-analysis of treatments for impetigo.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.